Integrating a Parenting Intervention Into Substance Use Treatment: A Feasibility Study

While motherhood is central to the design of maternal integrated substance use treatment programs, "evidence-based" parenting interventions tailored to the needs of the population are rare. Stakeholder engagement has revealed that the evidence-base is not reflective of the needs of client population. With 34 ECD programs in Ontario, ECD programs are unique position to pilot Attachment and Biobehavioral Catch Up (ABC) and see if it is a good fit for their clients and if it is effective and feasible. ABC is 10-week evidence-based parenting intervention for parents who live in the context of complex risk, including mental health, addictions, child welfare involvement, and poverty. Investigators of this project will complete a open label mixed method feasibility pilot study involving active implementation of ABC that will involve: 1. exploration facilitators and barriers of the year-long implementation and training process and 2. exploration of changes in maternal mental health, substance use and parenting outcomes from beginning to end of treatment. Results of this mixed method pilot study will inform a larger trial with a control group and support a funding application to support its completion.

Study Overview

• Status: Recruiting
• Conditions: Parenting

Detailed Description

While motherhood is central to the design of maternal integrated substance use treatment programs, there are few "evidence-based" parenting interventions tailored to the needs of the population. This study will address this limitation in current parenting intervention research by exploring if Attachment and Biobehavioral Catch Up (ABC) is well suited and feasible to implement within integrated maternal substance use outpatient treatment. ABC is 10-week evidence-based parenting intervention for parents who live in the context of complex risk, including mental health, addictions, child welfare involvement, and poverty. Investigators of this project will complete a open label mixed method feasibility pilot study involving active implementation of ABC that will involve: 1. exploration facilitators and barriers of the year-long implementation and training process and 2. exploration of changes in maternal mental health, substance use and parenting outcomes from beginning to end of treatment. Results of this mixed method pilot study will inform a larger trial with a control group and support a funding application to support its completion.

• Study Type: Observational
• Enrollment (Anticipated): 34

Contacts and Locations

• Study Contact: Name: Karen Milligan, PhD; Phone Number: 557054 4169795000; Email: cfwise@ryerson.ca
• Study Contact Backup: Name: Erica Rodrigues; Phone Number: 553235 4169795000; Email: mothers@ryerson.ca

Study Locations

• Canada
  • Ontario
    • Toronto, Ontario, Canada, M5B2K3
      • Recruiting
      • Ryerson University
      • Contact: Erica Rodrigues; Phone Number: 553325 4169795000; Email: mothers@ryerson.ca
      • Contact: Laura Herman; Phone Number: 553325 4167951255; Email: cfwise@ryerson.ca

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Female

• Sampling Method: Non-Probability Sample

Study Population

Mothers who experience vulnerability and are challenged by substance use disorder trauma, and/or poverty.

Description

Inclusion Criteria:

• Women pregnant/parenting children ages 6-24 months
• Women that are clients of participating ECD agencies

Exclusion Criteria:

-

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Maternal Sensitivity	Coded from observed parent-child interactions	9 minutes play session

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Reflective Functioning	Reflective Function (RF) 18-item questionnaire	5 minutes
Parental Reflective Functioning	Reflective Function Questionnaire (PRF-Q) 8-item questionnaire	5 minutes
Depression, Anxiety, and Stress	Depression, Anxiety and Stress Scale (DASS21) - 21 item questionnaire	8 minutes
Parenting Stress	Parental Stress Index (PSI) - Short Form, 36 item questionnaire	10 minutes
Perceived Social Support	Multidimensional Scale of Perceived Social Support (MSPS), 12 item questionnaire	5 minutes
Difficulties in Emotion Regulation	Difficulties in Emotion Regulation Scale-SF (DERS-SF), 18-item questionnaire	5 minutes
Substance use screener	Global Appraisal of Individual Needs (Substance Use) (GAIN), 5-item questionnaire	2 minutes
Interpersonal Emotion Regulation	Interpersonal Emotion Regulation Questionnaire (IERQ), 20-item	8 minutes

Collaborators and Investigators

• Sponsor: Ryerson University
• Collaborators: Niagara Health System; house of sophrosyne
• Investigators: Principal Investigator: Karen Milligan, PhD, Ryerson University

Study record dates

Study Major Dates

• Study Start (Actual): May 1, 2021
• Primary Completion (Anticipated): April 1, 2022
• Study Completion (Anticipated): April 1, 2022

Study Registration Dates

• First Submitted: March 2, 2021
• First Submitted That Met QC Criteria: March 4, 2021
• First Posted (Actual): March 5, 2021

Study Record Updates

• Last Update Posted (Actual): September 16, 2021
• Last Update Submitted That Met QC Criteria: September 13, 2021
• Last Verified: September 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Mental Disorders; Chemically-Induced Disorders; Substance-Related Disorders
• Other Study ID Numbers: ABCforECD

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No